Dr. Farhan Mohammad, MD

Dr. Mohammad practices at Medical City Surgery Center McKinney - HOPD in Mckinney, Texas.

Dr. Mohammad's NPI, 1184902512, was assigned on August 2, 2011. Dr. Mohammad graduated from Deccan College of Medical Sciences NTR in 2007. Dr. Mohammad holds Texas license R6246.

Dr. Mohammad's primary practice is Medical City Surgery Center McKinney - HOPD, at 4510 Medical Center Dr, Mckinney, TX 75069.

Dr. Mohammad's primary practice is Medical City Surgery Center McKinney - HOPD in Mckinney, Texas. Dr. Mohammad is also affiliated with Medical City McKinney Hospital. The medical group on file is Texas Oncology. Dmand AI also links Dr. Mohammad to 1 more hospital, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mohammad practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mohammad's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mohammad is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Mohammad's licenses on file in 2 states: Texas and New York.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Mohammad treats.

CMS data shows 62,461 Medicare services from Dr. Mohammad across 50 procedure codes in 2024, for 450 Medicare patients. Medicare paid $846,725 for them.

CMS counts 450 Medicare patients who saw Dr. Mohammad in 2024. The largest group is 65 to 74, with 191 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mohammad's median patient age at 65, with 59% women.

In 2024, Dr. Mohammad wrote 1,140 Medicare Part D claims for 189 patients. 75% of them were for generic drugs. CMS names the drug for 871 of them, across 27 drugs with 11 or more claims each, at $1,490,224 in total drug cost. In 2023, CMS named 473 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Mohammad for performance year 2024, reported through an alternative payment model (APM). Dr. Mohammad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mohammad as offering telehealth.

Dmand AI links 14 papers to Dr. Mohammad, published from 2010 to 2017. 2017 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Mohammad has published most often in Cureus. Dr. Mohammad's most frequent co-authors are Uroosa Ibrahim, MBBS, Shiksha Kedia, MD and Marcel Odaimi, MD.

CMS Open Payments shows 242 general payments to Dr. Mohammad from 53 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $686.

Dmand AI lists 1 award for Dr. Mohammad, most recently Teaching Associate in 2016.

Dr. Mohammad graduated from Deccan College of Medical Sciences NTR in 2007. Dr. Mohammad is a member of SHM.

Dr. Mohammad is in network with 24 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.